FeesSafety
Pluang+

TScan refocuses on in vivo TCR-T therapy for solid tumors, plans first patient dosing in Q4 2027

Company Fundamentals
12 Nov 2026, 14:00 WIB
GlobeNewsWire
View Source
Bullish
TScan refocuses on in vivo TCR-T therapy for solid tumors, plans first patient dosing in Q4 2027

TScan Therapeutics announced a strategic shift to prioritize its in vivo-engineered TCR-T cell therapy for solid tumors, advancing two lead candidates targeting PRAME and MAGE-A4 through IND-enabling studies. The company paused enrollment in its Phase 3 ALLOHA-2 study for TSC-101 due to funding constraints and is seeking strategic partners. With $73 million in cash, TScan expects to fund operations into late 2027 and aims to dose its first patient with the new solid tumor therapy by Q4 2027. Updated clinical data and FDA feedback are anticipated in early 2027, supporting further development.

TScan Therapeutics financial results and update provide context for readers. For those tracking health stocks, 84 of 150 traded on Pluang rose while 57 fell as of Nov 12, 2026 18:11 WIB. Notable movers include MRVI at USD 7.93 (+2.99%), LLY at USD 1,476.03 (+2.66%), and DFTX at USD 33.57 (-2.61%).

More News

Tilray's 10 Barrel, Widmer Brothers, and Hop Valley named official craft beer partners of Portland Trail Blazers.

Tilray's 10 Barrel, Widmer Brothers, and Hop Valley named official craft beer partners of Portland Trail Blazers.

Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...

Market News
Bullish
55 minutes ago
Titan Mining's nine-month Adjusted EBITDA jumps 146% to $19.8M, advancing U.S. critical minerals projects.

Titan Mining's nine-month Adjusted EBITDA jumps 146% to $19.8M, advancing U.S. critical minerals projects.

Titan Mining reported a 146% increase in nine-month Adjusted EBITDA to $19.8 million, driven by a 38% rise in revenue to $67.9 million. Despite some production delays, zinc output is expected to improve in Q4 2026. The company is progressing its U.S....

Company Fundamentals
Bullish
1 hour ago
Nexpu completes delivery of 10,000 resale robots worth $4.8M under existing contract

Nexpu completes delivery of 10,000 resale robots worth $4.8M under existing contract

Nexpu Ltd.'s subsidiary, Top Kingwin Hi Tech Inc., has finished delivering all 10,000 TK-D2C robots to Walkers Times International under a $4.8 million resale contract signed in 2025. The deliveries were completed in batches, with the final 5,000 uni...

Market News
Bullish
1 hour ago
Katapult Holdings reports Q3 2026 results with $753.9M revenue, $110.4M adjusted EBITDA, and $30M cost synergies from merger.

Katapult Holdings reports Q3 2026 results with $753.9M revenue, $110.4M adjusted EBITDA, and $30M cost synergies from merger.

Katapult Holdings announced its third quarter 2026 financial results, reporting total revenues of $753.9 million and an adjusted EBITDA of $110.4 million, reflecting a 23% increase year-over-year on a combined basis. The company completed a merger wi...

Company Fundamentals
Neutral
1 hour ago
Three-quarters of U.S. workers plan to freelance within 3 years, valuing independence over salary.

Three-quarters of U.S. workers plan to freelance within 3 years, valuing independence over salary.

A new report from Fiverr reveals that 81% of full-time U.S. employees want to become their own boss, with 42% prioritizing independence over higher pay. This trend, dubbed "The Great Flexit," shows workers quietly preparing to freelance by building A...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App